Takeda/Mersana Deal Adds To ADC Pipeline
This article was originally published in PharmAsia News
Executive Summary
Mersana Therapeutics is getting a vote of confidence from long-time partner Takeda as the two companies expand their collaboration in antibody-drug conjugates and plan to move a molecule into the clinic.